By Travis DeGraff


A victimology report out of Hawaii shows the severity of the liver damage caused by USP Labs OxyElite Pro.  Including 2 liver transplants, and one death.


It has been nearly a year since several reports of liver damage in Hawaii as a result of supplementing with USP Labs OxyElite Pro (OEP).  Up until now the information on the victims has been relatively limited.  For a long list of history on this developing story check out these articles on the Huffington post – http://www.huffingtonpost.com/tag/oxyelite-pro/

Earlier this week a letter to the editor was published in the American Journal of Gastroenterology [Ref 1].  The report was written by the doctors at the Queens Medical Center at the University of Honolulu, Hawaii.  This is where 8 people with liver damage were treated by doctors in their effort to save their livers, and their lives.  The report gives us a first hand look at some of the commonalities of those with liver damage as a result of taking USP Labs OEP.

I’ll put the entire patient table below.  But the notable findings and outcomes are:

  • 8 of 8 of the users were obese/overweight based on BMI
  • 7 of 8 were women
  • None of the 8 reported taking more than the recommended dose
  • 8 of 8 were Asian/South Pacific Islander
  • 2 of 8 required liver transplantation
  • 1 of 8 required liver transplantation, then ultimately died 17 days after presentation (48 year old Sonnette Marras – mother of 7)
  • 1 of 8 was stacking it with Versa-1 (USP Labs), which also contains aegeline

aegeline liver damage

Did USP Labs get in trouble?

Back in October 2013 the FDA sent USP Labs a warning letter indicating they must stop the sale of Aegeline containing products (OEP, and Versa-1).  That basically sent a message to anyone else selling it as well and at least one other company removed it from their product line.  The paper noted that since that time 43 other cases of liver damage were reported in Hawaii, as well as others in the continental United States.  Yet as of today no class action has been ruled upon for or against USP Labs for the sale of the new OEP and Versa-1.

At the same time USP Labs, and GNC just finished settling a class action lawsuit against the pair for the sale of their DMAA containing supplements Jack3d, and the first version of OEP [Ref 2].  In fact, the settlement resulted in a 2 million dollar payout to victims.  Still, for supplements that grossed revenues of 151 million in 2011 alone, it seems like a small punishment.  Some interesting notes from this lawsuit include the following (some of heavily influenced by my interpretations):

  • The lawsuit actually grabbed statements from forums made by Jacob (USP Labs owner).
  • They basically call all the USP labs funded Memphis studies garbage.  The lead researcher Dr. Bloomer was funded about a million dollars over 3 years.
  • It seems like GNC was included simply because they have deep pockets. One of the three listed plaintiffs didn’t even purchase at GNC.

At the end of the day I suspect we will see another settlement regarding Aegeline and its use in OEP and Versa-1.  Until that time we can only speculate.


Leave a Reply

Your email address will not be published. Required fields are marked *